IL91423A - Preparation for the treatment of blood clots - Google Patents

Preparation for the treatment of blood clots

Info

Publication number
IL91423A
IL91423A IL9142389A IL9142389A IL91423A IL 91423 A IL91423 A IL 91423A IL 9142389 A IL9142389 A IL 9142389A IL 9142389 A IL9142389 A IL 9142389A IL 91423 A IL91423 A IL 91423A
Authority
IL
Israel
Prior art keywords
leu
ala
gin
ser
pro
Prior art date
Application number
IL9142389A
Other languages
English (en)
Hebrew (he)
Other versions
IL91423A0 (en
Original Assignee
Chugai Seiyaku Kabishiki Kaish
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Seiyaku Kabishiki Kaish filed Critical Chugai Seiyaku Kabishiki Kaish
Publication of IL91423A0 publication Critical patent/IL91423A0/xx
Publication of IL91423A publication Critical patent/IL91423A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Networks Using Active Elements (AREA)
  • Surgical Instruments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL9142389A 1988-08-24 1989-08-24 Preparation for the treatment of blood clots IL91423A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21037688 1988-08-24

Publications (2)

Publication Number Publication Date
IL91423A0 IL91423A0 (en) 1990-04-29
IL91423A true IL91423A (en) 1995-06-29

Family

ID=16588321

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9142389A IL91423A (en) 1988-08-24 1989-08-24 Preparation for the treatment of blood clots

Country Status (8)

Country Link
US (1) US5202117A (fr)
EP (1) EP0355811B1 (fr)
KR (1) KR950003492B1 (fr)
AT (1) ATE97813T1 (fr)
CA (1) CA1339071C (fr)
DE (1) DE68911061T2 (fr)
IL (1) IL91423A (fr)
ZA (1) ZA896463B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120304D0 (en) * 1991-09-24 1991-11-06 Erba Carlo Spa Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor
FR2693907B1 (fr) * 1992-07-23 1994-09-02 Rhone Poulenc Rorer Sa Procédé d'administration de solutions de facteur de stimulation des colonies granulocytaires.
US5879794A (en) * 1994-08-25 1999-03-09 W. L. Gore & Associates, Inc. Adhesive-filler film composite
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
AU4902897A (en) 1996-11-08 1998-05-29 W.L. Gore & Associates, Inc. Method for improving reliability of thin circuit substrates by increasing the T of the substrate
AU749815B2 (en) * 1998-03-06 2002-07-04 Chugai Seiyaku Kabushiki Kaisha Protein-free preparations
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
WO2002099081A2 (fr) * 2001-06-07 2002-12-12 Quark Biotech, Inc. Methodes d'utilisation de facteurs de stimulation des colonies dans le traitement de tissus endommages et de l'ischemie
US7423007B2 (en) 2002-08-27 2008-09-09 Biokine Therapeutics Ltd. Cxcr4 antagonist and use thereof
US20090226397A1 (en) * 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
KR100812274B1 (ko) * 2006-10-30 2008-03-13 한양대학교 산학협력단 Ｇ-ｃｓｆ를 유효성분으로 하는 당뇨성 말초신경병 예방 및치료제
ES2842210T3 (es) 2006-12-21 2021-07-13 Biokine Therapeutics Ltd 4F-benzoil-TN14003 para la movilización de células progenitoras hematopoyéticas con vistas al trasplante
SG188143A1 (en) 2008-02-08 2013-03-28 Ambrx Inc Modified leptin polypeptides and their uses
NZ591235A (en) * 2008-07-23 2012-07-27 Ambrx Inc Modified bovine g-csf polypeptides comprising non natural amino acid and their uses treating infections such as mastitis
WO2010092571A2 (fr) 2009-02-11 2010-08-19 Yeda Research And Development Co. Ltd. Peptides courts dérivés de bêta-défensine
KR101719339B1 (ko) 2009-06-14 2017-03-23 바이오카인 테라퓨틱스 리미티드 혈소판 수준을 증가시키는 펩타이드 요법
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
EP2841084B1 (fr) 2012-04-24 2018-05-30 Biokine Therapeutics Ltd. Peptide antagoniste de cxcr4 et son utilisation pour le traitment de tumeurs pulmonaires
EP3744340A3 (fr) 2015-07-16 2021-03-03 Biokine Therapeutics Ltd. Compositions et procédés pour le traitement du cancer
AU2017222495B2 (en) 2016-02-23 2019-08-08 Biolinerx Ltd. Methods of treating acute myeloid leukemia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
KR960008010B1 (ko) * 1988-07-29 1996-06-19 오오쓰까세이야꾸 가부시끼가이샤 IL-1α 유도체 및 혈소판 감소증 치료 약제
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤

Also Published As

Publication number Publication date
DE68911061T2 (de) 1994-03-24
ZA896463B (en) 1990-05-30
EP0355811B1 (fr) 1993-12-01
EP0355811A2 (fr) 1990-02-28
US5202117A (en) 1993-04-13
AU625914B2 (en) 1992-07-16
EP0355811A3 (fr) 1991-03-20
KR950003492B1 (ko) 1995-04-13
KR900002800A (ko) 1990-03-23
AU4014789A (en) 1990-03-01
DE68911061D1 (de) 1994-01-13
ATE97813T1 (de) 1993-12-15
CA1339071C (fr) 1997-07-29
IL91423A0 (en) 1990-04-29

Similar Documents

Publication Publication Date Title
CA1339071C (fr) Agent antithrombotique
EP0506757B2 (fr) Derive du facteur humain viii de recombinaison
US4552760A (en) Method for stabilizing tissue plasminogen activator and a stable aqueous solution or powder containing the same
US5112609A (en) Acidic formulations of t-PA
US4968617A (en) Solid hydrochloride salt of t-PA
EP0326014A1 (fr) Composition d'anticoagulants
CA1338698C (fr) Methode de preparation d'une solution a haute concentration d'une proteine activateur tissulaire du plasminogene; solution renfermant une proteine de ce type et son utilisation enmedecine humaine et veterinaire
US7070958B2 (en) Methods of making pro-urokinase mutants
CA1308377C (fr) Complexe forme de polyethyleneglycol et d'activateur du plasminogene tissulaire
JP2907447B2 (ja) 抗血栓剤
EP0691850B1 (fr) Facteur xiii pour le traitement des lesions cutanees
EP0151996B1 (fr) Procédé de préparation d'un activateur de plasminogène double-chaîne
EP0163751B1 (fr) Procédé de préparation d'un activateur de plasminogène
JP2589094B2 (ja) 抗悪性腫瘍剤
US20020151481A1 (en) MMP-2 propeptide for use as antiangiogenic or antitumor agent
JPH0369332B2 (fr)
JP2697725B2 (ja) 悪性腫瘍治療用キット
EP0352897A1 (fr) Médicaments contenant le TPA
WO2010070746A1 (fr) Polypeptide de type angiostatine canine

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees